These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 9592997

  • 1. Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization.
    Gallichan WS, Rosenthal KL.
    J Infect Dis; 1998 May; 177(5):1155-61. PubMed ID: 9592997
    [Abstract] [Full Text] [Related]

  • 2. Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract.
    Gallichan WS, Woolstencroft RN, Guarasci T, McCluskie MJ, Davis HL, Rosenthal KL.
    J Immunol; 2001 Mar 01; 166(5):3451-7. PubMed ID: 11207303
    [Abstract] [Full Text] [Related]

  • 3. Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2.
    Kwant A, Rosenthal KL.
    Vaccine; 2004 Aug 13; 22(23-24):3098-104. PubMed ID: 15297061
    [Abstract] [Full Text] [Related]

  • 4. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
    Bagri P, Anipindi VC, Nguyen PV, Vitali D, Stämpfli MR, Kaushic C.
    J Virol; 2017 Dec 01; 91(23):. PubMed ID: 28956763
    [Abstract] [Full Text] [Related]

  • 5. Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus.
    Gallichan WS, Rosenthal KL.
    Vaccine; 1995 Nov 01; 13(16):1589-95. PubMed ID: 8578847
    [Abstract] [Full Text] [Related]

  • 6. Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract.
    Gallichan WS, Rosenthal KL.
    Virology; 1996 Oct 15; 224(2):487-97. PubMed ID: 8874509
    [Abstract] [Full Text] [Related]

  • 7. Targeting the genital tract mucosa with a lipopeptide/recombinant adenovirus prime/boost vaccine induces potent and long-lasting CD8+ T cell immunity against herpes: importance of MyD88.
    Zhang X, Dervillez X, Chentoufi AA, Badakhshan T, Bettahi I, Benmohamed L.
    J Immunol; 2012 Nov 01; 189(9):4496-509. PubMed ID: 23018456
    [Abstract] [Full Text] [Related]

  • 8. Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2.
    Gillgrass AE, Ashkar AA, Rosenthal KL, Kaushic C.
    J Virol; 2003 Sep 01; 77(18):9845-51. PubMed ID: 12941893
    [Abstract] [Full Text] [Related]

  • 9. Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract.
    Milligan GN, Bernstein DI.
    Virology; 1995 Jan 10; 206(1):234-41. PubMed ID: 7831778
    [Abstract] [Full Text] [Related]

  • 10. Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue.
    Gillgrass AE, Tang VA, Towarnicki KM, Rosenthal KL, Kaushic C.
    J Virol; 2005 Mar 10; 79(5):3117-26. PubMed ID: 15709031
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of genital T cell responses to herpes simplex virus type 2 resulting from immunization of the nasal mucosa.
    Milligan GN, Dudley-McClain KL, Chu CF, Young CG.
    Virology; 2004 Jan 20; 318(2):507-15. PubMed ID: 14972519
    [Abstract] [Full Text] [Related]

  • 12. A sustained type I IFN-neutrophil-IL-18 axis drives pathology during mucosal viral infection.
    Lebratti T, Lim YS, Cofie A, Andhey P, Jiang X, Scott J, Fabbrizi MR, Ozantürk AN, Pham C, Clemens R, Artyomov M, Dinauer M, Shin H.
    Elife; 2021 May 28; 10():. PubMed ID: 34047696
    [Abstract] [Full Text] [Related]

  • 13. Vaginal memory T cells induced by intranasal vaccination are critical for protective T cell recruitment and prevention of genital HSV-2 disease.
    Sato A, Suwanto A, Okabe M, Sato S, Nochi T, Imai T, Koyanagi N, Kunisawa J, Kawaguchi Y, Kiyono H.
    J Virol; 2014 Dec 28; 88(23):13699-708. PubMed ID: 25231301
    [Abstract] [Full Text] [Related]

  • 14. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.
    Milligan GN, Bernstein DI.
    Virology; 1995 Oct 01; 212(2):481-9. PubMed ID: 7571418
    [Abstract] [Full Text] [Related]

  • 15. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.
    Wizel B, Persson J, Thörn K, Nagy E, Harandi AM.
    Vaccine; 2012 Jun 19; 30(29):4361-8. PubMed ID: 22682292
    [Abstract] [Full Text] [Related]

  • 16. Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells.
    Morrison LA, Zhu L, Thebeau LG.
    J Virol; 2001 Feb 19; 75(3):1195-204. PubMed ID: 11152492
    [Abstract] [Full Text] [Related]

  • 17. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
    Tengvall S, O'Hagan D, Harandi AM.
    Antiviral Res; 2008 Jun 19; 78(3):202-14. PubMed ID: 18276020
    [Abstract] [Full Text] [Related]

  • 18. The application of a plasmid DNA encoding IFN-alpha 1 postinfection enhances cumulative survival of herpes simplex virus type 2 vaginally infected mice.
    Härle P, Noisakran S, Carr DJ.
    J Immunol; 2001 Feb 01; 166(3):1803-12. PubMed ID: 11160227
    [Abstract] [Full Text] [Related]

  • 19. A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.
    Awasthi S, Mahairas GG, Shaw CE, Huang ML, Koelle DM, Posavad C, Corey L, Friedman HM.
    J Virol; 2015 Aug 01; 89(16):8497-509. PubMed ID: 26041292
    [Abstract] [Full Text] [Related]

  • 20. Immunization with HSV-2 gB-CCL19 Fusion Constructs Protects Mice against Lethal Vaginal Challenge.
    Yan Y, Hu K, Deng X, Guan X, Luo S, Tong L, Du T, Fu M, Zhang M, Liu Y, Hu Q.
    J Immunol; 2015 Jul 01; 195(1):329-38. PubMed ID: 25994965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.